Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,905.89 -947.74 (-1.46%) CMC Crypto 200
1,332.30 -64.24 (-4.60%)
Omega Healthcare Investors, Inc. (OHI)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 7.63B |
| Enterprise value | 12.25B |
| Trailing P/E | 30.90 |
| Forward P/E | 10.13 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.15 |
| Price/book (mrq) | 2.13 |
| Enterprise value/revenue | 12.90 |
| Enterprise value/EBITDA | 15.11 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.90 |
| 52-week change 3 | 15.47% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 34.77 |
| 52-week low 3 | 26.11 |
| 50-day moving average 3 | 30.99 |
| 200-day moving average 3 | 31.44 |
Share statistics
| Avg vol (3-month) 3 | 1.79M |
| Avg vol (10-day) 3 | 1.42M |
| Shares outstanding 5 | 246.93M |
| Implied shares outstanding 6 | 253.91M |
| Float 8 | 244.36M |
| % held by insiders 1 | 0.29% |
| % held by institutions 1 | 66.61% |
| Shares short (15 Apr 2024) 4 | 13.4M |
| Short ratio (15 Apr 2024) 4 | 9.44 |
| Short % of float (15 Apr 2024) 4 | 7.35% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.43% |
| Shares short (prior month 15 Mar 2024) 4 | 12.99M |
Dividends & splits
| Forward annual dividend rate 4 | 2.68 |
| Forward annual dividend yield 4 | 8.67% |
| Trailing annual dividend rate 3 | 2.68 |
| Trailing annual dividend yield 3 | 8.67% |
| 5-year average dividend yield 4 | 8.30 |
| Payout ratio 4 | 268.00% |
| Dividend date 3 | 15 May 2024 |
| Ex-dividend date 4 | 29 Apr 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 25.50% |
| Operating margin (ttm) | 45.54% |
Management effectiveness
| Return on assets (ttm) | 3.30% |
| Return on equity (ttm) | 6.58% |
Income statement
| Revenue (ttm) | 949.74M |
| Revenue per share (ttm) | 3.95 |
| Quarterly revenue growth (yoy) | 65.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 799.2M |
| Net income avi to common (ttm) | 242.18M |
| Diluted EPS (ttm) | 1.00 |
| Quarterly earnings growth (yoy) | 20.70% |
Balance sheet
| Total cash (mrq) | 442.81M |
| Total cash per share (mrq) | 1.8 |
| Total debt (mrq) | 5.11B |
| Total debt/equity (mrq) | 135.70% |
| Current ratio (mrq) | 1.18 |
| Book value per share (mrq) | 14.57 |
Cash flow statement
| Operating cash flow (ttm) | 617.74M |
| Levered free cash flow (ttm) | 476.02M |
© 2024 Yahoo. All rights reserved.